Virginia Tech Study Finds Aging Life Care Managers® Deliver Critical Support, Trust, and Peace of Mind to Families Navigating Aging and Caregiving
Aging Life Care Managers are trained experts in aging, disability, and care coordination. They offer comprehensive support to families managing complex health conditions, navigating transitions, and coordinating services, while also serving as compassionate advocates and trusted partners in care.
Study Highlights Profound Impact on Families and Individuals
The two-phase research project, led by Dr. E. C. Shealy, Dr. P. B. Teaster, Dr. L. Sands, and Dr. J. Gray, involved in-depth interviews and a nationwide survey of current and former clients of Aging Life Care Managers. Findings reveal an overwhelmingly positive experience among families:
99% would recommend an Aging Life Care Manager
97% felt gratitude for the support received
93% said the value of the service outweighed the cost
Respondents frequently described their Aging Life Care Managers as "lifelines," especially in emergencies or when navigating complex family dynamics. Long-distance caregivers, in particular, expressed relief at having a knowledgeable, local expert they could trust.
A Model of Ethical, Compassionate Care
The study emphasized the ethical and person-centered foundation of the Aging Life Care™ model. Nearly all respondents affirmed their Aging Life Care Manager's professionalism, confidentiality, and advocacy:
97% said Aging Life Care Managers helped mediate family dynamics
96% noted strong knowledge of local providers
95% confirmed their privacy was protected
94% credited their Aging Life Care Manager with supporting balanced decision-making
"Aging Life Care Managers are not just professionals, they are partners, deeply committed to honoring the values and dignity of each client," said Pamela Teaster, Ph.D., professor and director of the Virginia Tech Center for Gerontology.
Emotional and Practical Support Through Every Stage
In addition to managing logistics, Aging Life Care Managers were praised for their emotional support and compassionate presence:
95% said their Aging Life Care Manager understood emotional challenges
91% found them responsive in crises
87% received help with care transitions
Families also reported a significant improvement in quality of life for both clients and themselves:
97% reported feeling peace of mind
92% affirmed their future needs were anticipated
87% said the client was able to "live well" despite their challenges
82% experienced reduced isolation
Client Testimonials Underscore Value
Comments from survey participants highlighted the personal and lasting impact of their Aging Life Care Managers:
"She's an extension of me.""It's worth every cent.""Even after her passing, the Aging Life Care Manager arranged a celebration."
A Call to Action for Families Nationwide
The findings affirm what many families have long known: Aging Life Care Managers offer critical support during some of life's most difficult times. Their unique blend of clinical knowledge, ethical practice, and emotional insight makes them essential partners in navigating aging, illness, and end-of-life care.
For those caring for aging loved ones or planning ahead, the Aging Life Care Association offers a nationwide directory of qualified professionals. Visit www.aginglifecare.org to learn more.
About the Study
The study, commissioned by the Aging Life Care Association® (ALCA), surveyed members of the Aging Life Care Association and their clients. An Examination of the Aging Life Care Association: Part Two – Qualitative Client Interviews and Client Survey was presented at the Aging Life Care Association's 41st Annual Conference in Boston, MA. Findings will be presented at the Gerontological Society of America Scientific Meeting in November 2025.
A summary of the study's findings can be found on the Aging Life Care Association's blog.
About the Aging Life Care Association® (ALCA)
The Aging Life Care Association® (ALCA) was formed in 1985 to advance dignified, coordinated care for older adults in the United States. With nearly 2,000 members nationwide, Aging Life Care Professionals® have cared for about two million older adults over its history. ALCA Members are distinguished from others practicing care management as they must meet stringent education, experience, and certification requirements and adhere to Code of Ethics and Standards of Practice. Members may be trained in several fields including, but not limited to, counseling, gerontology, mental health, nursing, occupational therapy, physical therapy, psychology, or social work; with a specialized focus on issues related to aging and elder care. For more information or to access a directory of Aging Life Care Professionals, please visit www.aginglifecare.org.
View original content to download multimedia:https://www.prnewswire.com/news-releases/virginia-tech-study-finds-aging-life-care-managers-deliver-critical-support-trust-and-peace-of-mind-to-families-navigating-aging-and-caregiving-302476887.html
SOURCE Aging Life Care Association
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Wound Care Market worth US$30.48 billion by 2030 with 6.5% CAGR
DELRAY BEACH, Fla., Aug. 11, 2025 /PRNewswire/ -- The global Wound Care Market, valued at US$20.97 billion in 2024 stood at US$22.22 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$30.48 billion by the end of the period. The wound care market is primarily driven by the increasing cases of traumatic and burn injuries, growing prevalence of chronic diseases, and rising geriatric population. These factors have contributed to the higher demand for effective wound management solutions. Additionally, supportive government initiatives and reimbursement frameworks further bolster market growth. However, the high cost of advanced wound care products and associated risks may limit their widespread adoption. On the other hand, emerging economies offer significant growth opportunities, supported by ongoing technological advancements in wound care. Despite this, market expansion is challenged by a shortage of trained healthcare professionals and limited awareness in underdeveloped regions. Download PDF Brochure: Browse in-depth TOC on "Wound Care Market" 589 - Tables 61 - Figures 457 - Pages By wound type, the wound care market is divided into two main segments based on wound type: chronic wounds and acute wounds. Chronic wounds are further divided into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other chronic wounds. The chronic wounds segment of the wound care held the largest market share in 2024. Chronic wounds are more prominent due to their high incidence and the need for quick, targeted treatment. These types of wounds require wound care products to prevent infection and support faster and efficient healing. Additionally, increasing surgical procedures and accidental injuries worldwide continue to drive demand in this segment. By end users, the wound care market is divided into hospitals & clinics, home care settings, long-term care facilities, and other end users. Among these end users, the hospitals & clinics segment held the largest market share in 2024 for wound care. Hospitals & clinics are further divided into inpatient settings and outpatient settings. Hospitals & clinics lead the market due to their ready access to advanced technologies and trained medical staff. These settings handle a larger number of complex wound patients, requiring specialized care. Their ability to provide immediate and continuous treatment further supports their dominant role in the market. By geography, the wound care market is segmented into five major segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America had the largest market share in the wound care market in 2024. This is due to the increasing prevalence of diabetes, which leads to diabetic foot ulcers in the geriatric population. Additionally, the huge presence of wound care manufacturing companies in the region is increasing the market growth. The US has also observed a rise in obesity and road accidents, which has boosted the wound care market in North America. Request Sample Pages : Prominent players in the wound care market include Solventum (US), Johnson & Johnson Services, Inc. (US), Smith+ Nephew (UK), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Mölnlycke AB (Sweden), Integra LifeSciences Corporation (US), PAUL HARTMANN AG (Germany), SE (Germany), Organogenesis Inc. (US), MIMEDX Group, Inc. (US), Essity Aktlebolag (Sweden), Avery Dennison Corporation (US), Mativ Holdings, Inc. (US), Owens & Minor (US), Zimmer Biomet (US), Bioventus (US), Medtronic (Ireland), and Baxter (US). Solventum (US): Following its spinoff from 3M in April 2024, Solventum embarked on a new journey as an independent company. While it previously benefited from 3M's resources and brand recognition, Solventum is now focused on establishing its own identity. The company develops, manufactures, and markets a wide range of products aimed at meeting the needs of both patients and healthcare providers. Its operations are structured across four key business segments: MedSurg, Dental Solutions, Health Information Systems, and Purification & Filtration. To drive growth, Solventum is prioritizing innovation and strategic expansion. The company enhances its competitive position by combining material science with digital technologies, delivering improved clinical and economic outcomes for healthcare systems. Johnson & Johnson Services, Inc. (US) Johnson & Johnson, a global healthcare powerhouse, maintains a leading position in the wound care market through its surgical technologies arm, Ethicon. The company provides an extensive portfolio of advanced wound closure solutions, including sutures, staplers, and sealants that are widely utilized in surgical and acute care environments. Leveraging decades of clinical expertise, strong evidence-based outcomes, and a commitment to continuous innovation, the company effectively addresses a broad spectrum of surgical wound care needs. Supported by Johnson & Johnson's expansive global manufacturing and distribution infrastructure, Ethicon strengthens the company's ability to deliver high-quality, scalable, and dependable wound care solutions worldwide. Smith+Nephew (UK) The company offers a wide portfolio of wound care products, including advanced dressings and NPWT devices. It maintains a strong global market presence, largely due to its efficient distribution network. Its worldwide reach and the essential nature of its products play a key role in expanding healthcare access across both developed and emerging markets. In recent years, the company has increased its focus on research and development to create more effective and differentiated products. It invested USD 289.0 million in 2024, USD 339.0 million in 2023, and USD 345.0 million in 2022 in R&D activities. This consistent commitment to innovation has helped establish the company as a recognized name in the wound care industry. For more information, Inquire Now! Related Reports: Advanced Wound Care Market Traditional Wound Care Market Animal Wound Care Market Wound Care Biologics Market Burn Care Market Get access to the latest updates on Wound Care Companies and Wound Care Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Sign in to access your portfolio
Entrepreneur
3 hours ago
- Entrepreneur
Eyestem Secures Funding to Advance Eyecyte-RPE Phase 2 Clinical Trial
The proceeds will be directed towards completing the ongoing Phase 2 clinical trial of its retinal pigment epithelial cell therapy, Eyecyte-RPE™, in India and preparing for an Investigational New Drug application with the United States Food and Drug Administration. You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Eyestem Research Pvt Ltd has secured funding from existing investors along with a new strategic partner in a significantly oversubscribed round. The proceeds will be directed towards completing the ongoing Phase 2 clinical trial of its retinal pigment epithelial cell therapy, Eyecyte-RPE™, in India and preparing for an Investigational New Drug application with the United States Food and Drug Administration. Dr Jogin Desai, Founder and Chief Executive Officer of Eyestem, said, "Strong participation by internal investors and addition of a strategic investor underline the shared belief in Eyestem's long-term vision of creating an innovative cell therapy platform providing scalable solutions for incurable diseases worldwide. This USD 10 million fundraise will support the next leg of development and strengthen the foundation for global expansion. We continue to prioritise rigorous clinical progress and the capabilities needed to ensure global patient access to this therapy." Raju Barwale, Chairman of Mahyco, and Sandeep Singh, Managing Director of Alkem Laboratories Ltd, stated, "Eyestem's pioneering treatment is delivering remarkable outcomes that set a new benchmark in ophthalmic cell therapy. The results observed in Phase 1 not only demonstrate promising efficacy compared to other ongoing global trials but also validate India's potential as a leader in advanced cell therapy innovations. We are privileged to support a breakthrough that has the potential to redefine treatment outcomes for millions suffering from dry AMD." Eyecyte-RPE™ is intended for patients with geographic atrophy, a severe stage of dry age-related macular degeneration. In the completed Phase 1 trial involving patients with advanced disease and severe vision loss, the therapy demonstrated a strong safety profile with no serious adverse events and showed early clinical benefits. These included an average improvement of 15.8 letters in six patients over six months and an average improvement of 11 letters in two patients over one year. The Phase 2 trial will assess the product in a larger group of patients with moderate disease. Founded by Dr Jogin Desai and a team of experts with decades of experience in pharmaceutical product development, retinal surgery, and cell biology, Eyestem is headquartered in Bengaluru and Delaware. Its proprietary Eyecyte-RPE™ therapy is derived from human induced pluripotent stem cells and is designed to replace damaged retinal cells, offering potential regeneration of diseased tissue.
Yahoo
4 hours ago
- Yahoo
NESA Becomes First Inpatient Virtual Care Platform Officially Listed in Epic Toolbox
MIAMI, Aug. 11, 2025 /PRNewswire/ -- NESA, a leader in AI-enabled virtual care solutions, today announced that its flagship product, the NESA Virtual Care Platform™, is the first Inpatient Virtual Care solution to receive Epic's Toolbox designation. This achievement indicates NESA's Virtual Care Platform has been rigorously tested and validated by Epic to ensure it meets Inpatient integration and functionality standards. The Toolbox designation further validates NESA's unique ability to deliver high-quality, scalable virtual care through an intuitive, fully embedded user experience. NESA empowers healthcare organizations to enhance care delivery by enabling virtual care capabilities where care teams already work—directly within the Epic EHR. With support for unlimited workflows for patients of all ages, the platform enhances clinician visibility, streamlines care coordination, and improves the overall patient experience. NESA is already deployed across North America and Europe and continues to expand globally. "This journey started in 2020 when NESA first started working with Epic. Through our close collaboration, NESA is fulfilling our commitment to meet clinicians where they are," said Neil Salem, CEO of NESA. "We're proud to help healthcare systems deliver better, more efficient, effective, and connected care for both patients and providers within the Epic eco-system." Better is our Starting Point: Designed to Streamline Care Delivery Unlike traditional virtual care models that add complexity and disruption, NESA's platform offers a single-pane-of-glass interface that streamlines care interactions and keeps clinicians focused. The embedded experience makes it easier than ever to engage in virtual consults, monitor patients, and coordinate care—all within Epic. Key Features of the NESA Platform Include: Epic ECAL/CAL Integration: Meets the standards of Epic's Embedded Context-Aware Linking (ECAL) and Context-Aware Linking (CAL) for Virtual Care. Natively Embedded in Epic: Integrates seamlessly with Epic Hyperspace, MyChart, Rover, Canto, and Haiku, allowing one-click access to virtual care sessions. Epic MyChart Bedside TV Integration: Enables in-patient access to medical records and care team communication from the bedside. AI-Enabled, Edge-Based Virtual Care: Delivers two-way audio and video, edge-based ambient listening, computer vision, and actionable analytics. Multi-Participant Support: Supports up to six simultaneous virtual participants for care team, patients and family members. Enterprise-Grade Hardware: NDAA-compliant dual-camera systems for picture-in-picture views, up to 32x zoom, night vision, HD voice and ambient noise suppression. Flexible Deployments: Available in fixed in-room, wall-mounted, or mobile all-in-one units to suit varied clinical needs. NESA is exhibiting at the Epic Annual Users Group Meeting (UGM) in Verona, WI, August 18-21. Visit NESA's booth to learn more about innovations in virtual care. About NESA NESA augments care delivery with its AI-enabled Virtual Care platform. The solution is designed to meet care teams where they already work—directly within the EHR. Rather than adding another layer of complexity, the platform supports a wide range of workflows, network-wide, across inpatient and outpatient settings, for patients of all ages. NESA's platform offers a single pane of glass view that streamlines all care interactions, helping clinicians maintain focus, reduce friction, and spend more time with patients. It functions 24/7 and adapts to existing routines, minimizing disruption while improving continuity. Learn more at Epic, MyChart, Toolbox, Hyperspace, Rover, Canto, and Haiku are registered trademarks of Epic Systems Corporation. NESA is a trademark of NESA, Inc. View original content to download multimedia: SOURCE NESA Sign in to access your portfolio
